Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
139.95B | 149.54B | 138.22B | 130.18B | 123.48B | 118.01B | Gross Profit |
33.91B | 35.44B | 33.64B | 31.92B | 30.98B | 29.38B | EBIT |
8.07B | 8.21B | 8.08B | 7.86B | 8.25B | 7.29B | EBITDA |
13.73B | 12.47B | 13.13B | 11.86B | 12.21B | 10.94B | Net Income Common Stockholders |
6.29B | 4.73B | 5.81B | 6.11B | 5.81B | 5.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.29B | 26.86B | 31.68B | 37.00B | 36.16B | 35.24B | Total Assets |
111.70B | 113.95B | 114.93B | 110.78B | 105.90B | 102.18B | Total Debt |
1.62B | 2.12B | 1.82B | 2.30B | 2.72B | 3.12B | Net Debt |
-27.28B | -23.34B | -29.17B | -33.77B | -33.08B | -32.03B | Total Liabilities |
27.58B | 28.10B | 28.14B | 28.56B | 28.38B | 28.30B | Stockholders Equity |
83.50B | 85.19B | 86.18B | 81.65B | 77.00B | 73.39B |
Cash Flow | Free Cash Flow | ||||
4.65B | 5.99B | -664.00M | 2.37B | 5.99B | 5.95B | Operating Cash Flow |
4.65B | 10.10B | 8.04B | 8.59B | 10.13B | 9.23B | Investing Cash Flow |
0.00 | -11.41B | -10.21B | -6.24B | -6.74B | -4.20B | Financing Cash Flow |
0.00 | -5.20B | -3.20B | -2.43B | -2.90B | -1.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥41.79B | 9.18 | 4.52% | -12.98% | 3.23% | ||
78 Outperform | ¥12.16B | 8.19 | 2.73% | 2.12% | -6.76% | ||
78 Outperform | ¥38.51B | 5.74 | 0.50% | 12.06% | -44.99% | ||
76 Outperform | ¥109.21B | 8.74 | 2.87% | 8.56% | 16.30% | ||
76 Outperform | ¥10.33B | 8.08 | 4.19% | 6.95% | 4.92% | ||
75 Outperform | ¥76.77B | 15.64 | 2.67% | 8.19% | -15.84% | ||
54 Neutral | $5.38B | 3.40 | -45.06% | 3.28% | 16.75% | -0.02% |
TOKAI Corp. has announced its Medium-term Management Plan for FY2026 to FY2028, focusing on increasing profitability and creating new value to achieve its Vision 2035. The plan includes reforming business structures, developing new businesses, maximizing group synergies, and investing in human capital to drive growth and shareholder returns.
Tokai Corp. has issued corrections to its previously announced consolidated financial results for the fiscal year ending March 31, 2025. The corrections pertain to the scheduled dates for the annual general meeting of shareholders and the commencement of dividend payments, which have been adjusted to June 26, 2025, and June 27, 2025, respectively. These changes reflect Tokai’s commitment to accurate and timely communication with its stakeholders.
Tokai Corp. announced changes to its board of directors, with new appointments and retirements set to be confirmed at the upcoming Annual General Meeting. These changes are expected to impact the company’s governance structure, potentially influencing its strategic direction and stakeholder relations.
TOKAI Corp. announced an expected extraordinary loss of 1.87 billion yen due to impairment losses on fixed assets related to its dispensing pharmacy and elderly care equipment businesses. Despite this, the company revised its earnings forecast upward for net sales, operating profit, and ordinary profit due to strong performance in its core rental business and recent acquisitions. However, the profit attributable to owners of the parent is expected to decrease due to the impairment losses. The year-end dividend remains unchanged, resulting in an annual dividend of 58 yen per share.